Retail pharmacy giant Dis-Chem is set to unveil a significantly revised rewards programme in the second half of the current financial year. The move comes as the retailer aims to regain lost market share in key categories. This follows intense promotional activity...
Clicks Group is undeniably a powerhouse on the JSE. It is widely recognised as a well-managed and resilient business. However, a persistent question dogs potential investors, particularly those inclined towards scepticism: is Clicks Group simply too expensive to...
The landscape of weight management and diabetes treatment in South Africa is undergoing a dramatic transformation. This change is driven by the meteoric rise in popularity of a class of drugs known as GLP-1s, including Ozempic and Mounjaro. These medications,...
JSE-listed Clicks Group has released its Clicks interim results for the six months ending February 2025. They report impressive resilience and strategic accomplishments in the health and beauty retail sector. The group noted a 13.2% rise in headline earnings per share...
South Africa’s two largest pharmacy chains, Clicks and Dis-Chem, are pushing aggressive expansion plans, reflecting market optimism about their future growth. Both companies are enhancing their presence through new store rollouts and a strong focus on loyalty...
